Ling Rui Pharmaceutical announced that Xinrui Investment plans to reduce its shareholding by no more than 1.92%.
羚锐制药：新锐投资拟减持股份不超过1.92%
Ling Rui Pharmaceutical: Xinrui Investment plans to reduce its shareholding by no more than 1.92%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.